Skip to main content
. 2022 Jul 18;10(7):1143. doi: 10.3390/vaccines10071143

Figure 1.

Figure 1

Anti-S antibody titer 1 (T1) and 4 months (T2) after the third vaccine dose. Participants with SARS-CoV-2 infection showed higher anti-S antibody levels than those without infection. In addition, in non-infected participants, the antibody level at 4 months after the third dose of vaccination was significantly lower than at 1 month.